Biological & Chemical Warfare
ATTACK
on AMERICA
Biological & Chemical
Spending
Preparing for Attack
Vaccines
Anthrax
Botulin
Yersinia
Pestis
Contagious
Diseases
VX
Nerve
Agents
Mustard Gas

Contagious Diseases


EBOLA

• Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys and chimpanzees) that has appeared sporadically since its initial recognition in 1976.

• After the first case-patient in an outbreak setting (often called the index case) is infected, humans can transmit the virus in several ways. People can be exposed to Ebola virus from direct contact with the blood and/or secretions of an infected person. This is why the virus has often been spread through the families and friends of infected persons: in the course of feeding, holding, or otherwise caring for them, family members and friends would come into close contact with such secretions. People can also be exposed to Ebola virus through contact with objects, such as needles, that have been contaminated with infected secretions.

• Within a few days of becoming infected with the virus:

Symptoms that occur in most Ebola patients:
high fever, headache, muscle aches, stomach pain, fatigue, diarrhea

Symptoms that occur in some Ebola patients:
chest pain, shock, and death

• Within one week of becoming infected with the virus:

Symptoms that occur in most Ebola patients:
sore throat, hiccups, rash, red and itchy eyes, vomiting blood, bloody diarrhea

Symptoms that occur in some Ebola patients:
blindness, bleeding

• There is no standard treatment for Ebola HF. Currently, patients receive supportive therapy. This consists of balancing the patient's fluids and electrolytes, maintaining their oxygen status and blood pressure, and treating them for any complicating infections.

CHOLERA

• Cholera is an acute, diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae. The infection is often mild or without symptoms, but sometimes it can be severe. Approximately one in 20 infected persons has severe disease characterized by profuse watery diarrhea, vomiting, and leg cramps. In these persons, rapid loss of body fluids leads to dehydration and shock. Without treatment, death can occur within hours.

• Cholera can be simply and successfully treated by immediate replacement of the fluid and salts lost through diarrhea. Patients can be treated with oral rehydration solution, a prepackaged mixture of sugar and salts to be mixed with water and drunk in large amounts. This solution is used throughout the world to treat diarrhea. Severe cases also require intravenous fluid replacement. With prompt rehydration, fewer than 1% of cholera patients die. Antibiotics shorten the course and diminish the severity of the illness, but they are not as important as rehydration.

• At the present time, the manufacture and sale of the only licensed cholera vaccine in the United States (Wyeth-Ayerst) has been discontinued. It has not been recommended for travelers because of the brief and incomplete immunity if offers. No cholera vaccination requirements exist for entry or exit in any country.

DIPHTHERIA

• Respiratory diphtheria presents as a sore throat with low-grade fever and an adherent membrane of the tonsils, pharynx, or nose. Neck swelling is usually present in severe disease. Cutaneous diphtheria presents as infected skin lesions which lack a characteristic appearance.

• Myocarditis, polyneuritis, and airway obstruction are common complications of respiratory diphtheria; death occurs in 5%-10% of respiratory cases. Complications and deaths are much less frequent in cutaneous diphtheria.

• Direct person- to-person transmission by intimate respiratory and physical contact. Cutaneous lesions are important in transmission.

CDC fact sheet on viral hemorrhagic fevers (including ebola)

SOURCE: Centers for Disease Control



Breaking News | U.S. Strikes Back | Bioterror |Attack Aftermath | The U.S. Response
Economic Impact | The Investigation | The Middle East | Analysis/Perspective | Military Action
Images/Multimedia | En Español | Journalist Bios